17 results on '"Aramaki, T."'
Search Results
2. Predictive score for identifying intrahepatic cholangiocarcinoma patients without lymph node metastasis: a basis for omitting lymph node dissection.
- Author
-
Miura Y, Ashida R, Ohgi K, Yamada M, Kato Y, Otsuka S, Aramaki T, Kakuda Y, Uesaka K, and Sugiura T
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Aged, Risk Factors, Multidetector Computed Tomography, Multivariate Analysis, Logistic Models, Decision Support Techniques, Adult, Lymph Nodes pathology, Odds Ratio, Chi-Square Distribution, Aged, 80 and over, Antigens, Tumor-Associated, Carbohydrate, Cholangiocarcinoma surgery, Cholangiocarcinoma pathology, Cholangiocarcinoma secondary, Cholangiocarcinoma diagnostic imaging, Bile Duct Neoplasms pathology, Bile Duct Neoplasms surgery, Predictive Value of Tests, Lymph Node Excision, Lymphatic Metastasis, Hepatectomy, CA-19-9 Antigen blood
- Abstract
Background: This study aimed to develop a predictive score for intrahepatic cholangiocarcinoma (ICC) in patients without lymph node metastasis (LNM) using preoperative factors., Methods: A retrospective analysis of 113 ICC patients who underwent liver resection with systemic lymph node dissection between 2002 and 2021 was conducted. A multivariate logistic regression analysis was used as a predictive scoring system for node-negative patients based on the β coefficients of preoperatively available factors., Results: LNM was observed in 36 patients (31.9%). Four factors were associated with LNM: suspicion of LNM on MDCT (odds ratio [OR] 13.40, p < 0.001), low-vascularity tumor (OR 6.28, p = 0.005), CA19-9 ≥500 U/mL (OR 5.90, p = 0.010), and tumor location in the left lobe (OR 3.67, p = 0.057). The predictive scoring system was created using these factors (assigning 3 points for suspected LNM on MDCT, 2 points for CA19-9 ≥500 U/mL, 2 points for low vascularity tumor, and 1 point for tumor location in the left lobe). A score cutoff value of 4 resulted in 0.861 sensitivity and a negative predictive value of 0.922 for detecting LNM. Notably, no patients with peripheral tumors and a score of ≤3 had LNM., Conclusion: The developed scoring system may effectively help identify ICC patients without LNM., Competing Interests: Conflict of interest None declared., (Copyright © 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. The presence of an intron relieves gene repression caused by promoter-proximal four-bp specific sequences in yeast.
- Author
-
Kikuta H, Aramaki T, Mabu S, Akada R, and Hoshida H
- Subjects
- Introns genetics, 5' Untranslated Regions, Gene Expression Regulation, Plant, Gene Expression, RNA-Binding Proteins genetics, Saccharomyces cerevisiae genetics, Saccharomyces cerevisiae Proteins genetics
- Abstract
Introns can enhance gene expression in eukaryotic cells in a process called intron-mediated enhancement (IME). The levels of enhancement are affected not only by the intron sequence but also by coding sequences (CDSs). However, the parts of CDSs responsible for mediating IME have not yet been identified. In this study, we identified an IME-mediating sequence by analyzing three pairs of IME-sensitive and -insensitive CDSs in Saccharomyces cerevisiae. Expression of the CDSs yCLuc, yRoGLU1, and KmBGA1 was enhanced by the presence of an intron (i.e., they were IME sensitive), but the expression of each corresponding codon-changed CDS, which encoded the identical amino acid sequence, was not enhanced (i.e., they were IME insensitive). Interestingly, the IME-insensitive CDSs showed higher expression levels that were like intron-enhanced expression of IME-sensitive CDSs, suggesting that expression of IME-sensitive CDSs was repressed. A four-nucleotide sequence (TCTT) located in the promoter-proximal position of either the untranslated or coding region was found to be responsible for repression in IME-sensitive CDSs, and repression caused by the TCTT sequence was relieved by the presence of an intron. Further, it was found that the expression of intron-containing yeast-native genes, UBC4 and MPT5, was repressed by TCTT in the CDS but relieved by the introns. These results indicate that TCTT sequences in promoter-proximal positions repress gene expression and that introns play a role in relieving gene repression caused by sequences such as TCTT., Competing Interests: Declaration of competing interest None., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Portal vein thrombosis after right hepatectomy: impact of portal vein resection and morphological changes of the portal vein.
- Author
-
Terasaki F, Ohgi K, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Yamada M, Otsuka S, Aramaki T, and Uesaka K
- Subjects
- Hepatectomy adverse effects, Hepatectomy methods, Humans, Liver Cirrhosis surgery, Portal Vein diagnostic imaging, Portal Vein pathology, Portal Vein surgery, Retrospective Studies, Splenectomy adverse effects, Liver Diseases surgery, Venous Thrombosis diagnostic imaging, Venous Thrombosis etiology, Venous Thrombosis pathology
- Abstract
Background: Right hepatectomy occasionally requires portal vein resection (PVR) and causes postoperative portal vein thrombosis (PVT)., Methods: A total of 247 patients who underwent right hepatectomy were evaluated using a three-dimensional analyzer to identify the morphologic changes in the portal vein (PV). The patients' characteristics were compared between the PVR group (n = 73) and non-PVR group (n = 174), and risk factors for PVT were investigated. The PVR group were subdivided into the wedge resection (WR) group (n = 38) and segmental resection (SR) group (n= 35)., Results: Postoperative PVT occurred in 20 patients (8.1%). Multivariate analyses in all patients revealed that postoperative left PV diameter/main PV diameter (L/M ratio) <0.56 (odds ratio [OR] 4.00, p = 0.009) and PVR (OR 3.31, p = 0.031) were significant risk factors for PVT. In 73 patients who underwent PVR, PVT occurred in 14 (19%) and WR (OR 11.5, p = 0.005) and L/M ratio <0.56 (OR 5.51, p = 0.016) were significant risk factors for PVT., Conclusion: PVR was one of the significant risk factors for PVT after right hepatectomy. SR rather than WR may be recommended for preventing PVT., Competing Interests: Conflict of interest None to declare., (Copyright © 2021 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
5. Mechanical role of actinotrichia in shaping the caudal fin of zebrafish.
- Author
-
Nakagawa H, Kuroda J, Aramaki T, and Kondo S
- Subjects
- Animals, Collagen Type IX metabolism, Gene Expression Regulation, Developmental, Gene Knockout Techniques, Zebrafish genetics, Zebrafish Proteins metabolism, Animal Fins embryology, Collagen Type IX deficiency, Zebrafish embryology, Zebrafish Proteins deficiency
- Abstract
Spear-like collagen complexes, known as actinotrichia, underlie the epidermal cell layer in the tip of teleost fins and are known to contribute toward fin formation; however, their specific role remains largely unclear. In this study, we investigated of actinotrichia in the role of caudal fin formation by generating collagen9a1c (col9a1c)-knockout zebrafish. Although actinotrichia were initially produced normally and aligned correctly in the knockout fish, the number of actinotrichia decreased as the fish grew and their alignment became disordered. Simultaneously, the fin tip gradually shortened in the dorsal-ventral direction and the entire fin became oval-shaped, while the fin-rays rarely bifurcated and instead underwent fusion, suggesting that actinotrichia are essential for spreading fins dorsoventrally. Furthermore, the epithelial cells that are usually thinly spread in normal fish became spherical in the knockout fish, reducing the area covered by each cell and thus the area of the fin tip. Together, these findings suggest that the tight alignment of actinotrichia provides physical support in the dorsal-ventral direction that allows caudal fins to expand in a triangular-shape., Competing Interests: Declaration of competing interest The authors declare no competing or financial interests., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Method for disarranging the pigment pattern of zebrafish by optogenetics.
- Author
-
Aramaki T and Kondo S
- Subjects
- Animals, Animals, Genetically Modified, Body Patterning genetics, Channelrhodopsins genetics, Channelrhodopsins metabolism, Embryonic Development genetics, Melanophores metabolism, Skin Pigmentation genetics, Zebrafish genetics, Body Patterning physiology, Embryonic Development physiology, Optogenetics methods, Skin Pigmentation physiology
- Abstract
To investigate the spatiotemporal dynamics of skin pattern formation, we developed a simple method for artificially disarranging the placement of all three pigment cell types in the body trunk of zebrafish (Danio rerio). We generated transgenic fish with melanophores that ectopically expressed a variant of channelrhodopsin-2 (ChR2). Blue light (BL) irradiation induced melanophore depolarization and random migration; the latter resulted in the disarrangement of the two other pigment cell types (xanthophores and iridophores). This BL disarrangement (BLD) method was effective in both young and adult fish, but it did not affect the initial placement of pigment cells in juvenile fish (approximately 5 weeks post-fertilization). Irradiation with BL was not harmful to cells, and the patterning process immediately resumed when BL was switched off. Using the BLD method, we demonstrated that interactions between pigment cells determined stripe width in the absence of any pre-set positional cues, while the initial horizontal alignment of iridophores determined their directionality. The BLD method can be adapted to any zebrafish skin-pattern mutant, providing a novel tool for analyzing pattern formation mechanisms under a variety of conditions and facilitating further study in this field., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
7. Pancreatic attenuation on computed tomography predicts pancreatic fistula after pancreaticoduodenectomy.
- Author
-
Ohgi K, Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Aramaki T, and Uesaka K
- Subjects
- Aged, Body Mass Index, Female, Humans, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Pancreatic Ducts pathology, Pancreatic Fistula diagnosis, Pancreatic Neoplasms pathology, Pancreatic Neoplasms surgery, Postoperative Complications diagnosis, Predictive Value of Tests, Retrospective Studies, Pancreatic Fistula epidemiology, Pancreatic Neoplasms diagnostic imaging, Pancreaticoduodenectomy adverse effects, Postoperative Complications epidemiology, Tomography, X-Ray Computed
- Abstract
Background: Some parameters using preoperative computed tomography (CT) have been evaluated to predict the development of pancreatic fistula (PF) after pancreaticoduodenectomy (PD). The present retrospective study evaluated the predictive value of pancreatic attenuation for PF after PD., Methods: A retrospective review was conducted of the patients who underwent PD between January 2010 and December 2014. The pancreatic attenuation was measured in unenhanced preoperative CT images. Pre- and intraoperative variables were analyzed for the risk of PF after PD., Results: Of the 346 consecutive patients, PF occurred in 116 (34%). The pancreatic attenuation was significantly greater in patients with PF than in those without PF (median, 40.0 vs. 33.3 Hounsfield units [HU], P < 0.001). A multivariate analysis showed that a pancreatic attenuation ≥30.0 HU (odds ratio [OR], 3.72; P < 0.001), a body mass index ≥25.0 kg/m
2 (OR, 3.67; P < 0.001) and a diameter of the main pancreatic duct <3.0 mm (OR, 1.84; P = 0.034) were independent risk factors for PF after PD., Conclusion: The degree of pancreatic attenuation on preoperative CT images was significantly associated with PF, and a pancreatic attenuation ≥30.0 HU was an independent risk factor of PF after PD., (Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
8. Current status of the megabenthic community in coastal Fukushima Prefecture, Japan, in the wake of the Great East Japan Earthquake.
- Author
-
Kodama K, Aramaki T, and Horiguchi T
- Subjects
- Animals, Biodiversity, Biomass, Japan, Aquatic Organisms, Earthquakes, Environmental Monitoring, Invertebrates
- Abstract
We conducted fisheries-independent bottom-trawl surveys along the coast of Fukushima, Japan, from 2013 to 2017 to study the megabenthic community structure after the 2011 earthquake, tsunami, and nuclear disaster. Although we observed no substantial changes in biodiversity, total abundance and biomass fluctuated among years, primarily because of temporary increases in the abundance or biomass of small shrimp and squid, or variations in abundance or biomass of mid-sized fishes (i.e. puffers and flatfishes) and large elasmobranchs. Echinoderm abundance and biomass decreased in all areas. Crustacean abundance and biomass were extremely low in the central and southern offshore transects. Our results suggest that there has been no recognizable recovery in the megabenthic community, and megabenthic species off the coast of Fukushima might have been experiencing reproductive or recruitment failure. Further research is needed to reveal the causal factors behind changes in these megabenthic communities., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
9. Radiocesium in seawater, sediments, and marine megabenthic species in coastal waters off Fukushima in 2012-2016, after the 2011 nuclear disaster.
- Author
-
Horiguchi T, Kodama K, Aramaki T, Miyata Y, and Nagao S
- Subjects
- Animals, Disasters, Japan, Seawater, Water Pollution, Radioactive statistics & numerical data, Cesium Radioisotopes analysis, Fukushima Nuclear Accident, Radiation Monitoring, Water Pollutants, Radioactive analysis
- Abstract
In bottom-sediment samples collected in 2012 from a coastal strip (∼30 km × 120 km) off the Fukushima Daiichi Nuclear Power Plant (FDNPP), radiocesium activity concentrations were generally higher south of the FDNPP, with high activity concentration patches in the north. In periodic surveys conducted at nearshore sites during 2012-2016, no clear temporal trends were observed in radiocesium activity concentrations in seawater or bottom sediment, and activity concentrations were higher in fish than in invertebrates. During 2012-2014, radiocesium activity concentrations tended to decrease in fish, but during 2012-2013 in the south, some increases were observed. Radiocesium activity concentrations were significantly higher in some fish (e.g., Okamejei kenojei) directly offshore and south of the FDNPP than in the north. Activity concentrations in fish stomach contents were significantly correlated with those in muscle tissue, suggesting that the consumption of contaminated prey contributed greatly to radiocesium contamination in demersal fish., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
10. Hepatic arterial infusion of 5-fluorouracil for patients with liver metastases from colorectal cancer refractory to standard systemic chemotherapy: a multicenter, retrospective analysis.
- Author
-
Nishiofuku H, Tanaka T, Aramaki T, Boku N, Inaba Y, Sato Y, Matsuoka M, Otsuji T, Arai Y, and Kichikawa K
- Subjects
- Adult, Aged, Colorectal Neoplasms pathology, Female, Follow-Up Studies, Humans, Infusions, Intra-Arterial, Liver Neoplasms secondary, Male, Middle Aged, Retrospective Studies, Survival Rate, Treatment Outcome, Antimetabolites, Antineoplastic administration & dosage, Colorectal Neoplasms drug therapy, Fluorouracil administration & dosage, Hepatic Artery, Liver Neoplasms drug therapy, Salvage Therapy
- Abstract
Introduction: This retrospective study evaluated the safety and efficacy of hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil (5-FU) for patients with liver metastases from colorectal cancer refractory to standard systemic chemotherapy., Patients and Methods: Fifty-five patients who had shown disease progression during the prior standard systemic chemotherapy with oxaliplatin, irinotecan, and 5-FU were enrolled. The treatment was weekly HAIC with 5-FU 1000 mg/m2/5 hours through an indwelling catheter-port system., Results: No major adverse reaction was observed other than grade 3 leukocytopenia (3.6%) and hyperbilirubinemia (1.8%). The overall response rate and disease control rate were 18.2% and 70.9%, respectively. The median progression-free survival and median overall survival (OS) were 2.8 months, and 6.7 months, respectively. The initial sites of disease progression were liver in 14, other than liver in 27, and both in 6. Multivariate analysis identified Eastern Cooperative Oncology Group (ECOG) performance status (PS) ≤ 1 and number of extrahepatic metastatic sites (NMS) ≤ 1 as favorable prognostic factors for OS (hazard ratio [HR], 8.277; 95% CI, 3.60-19.0; P = .000 for ECOG PS; and HR, 2.456; 95% CI, 1.30-4.61; P = .005 for NMS)., Conclusion: HAIC with 5-FU may be a safe and effective treatment for patients with colorectal liver metastases refractory to standard systemic chemotherapy.
- Published
- 2010
- Full Text
- View/download PDF
11. La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity.
- Author
-
Huang M, Ida H, Arima K, Nakamura H, Aramaki T, Fujikawa K, Tamai M, Kamachi M, Kawakami A, Yamasaki H, Origuchi T, and Eguchi K
- Subjects
- Autoantigens genetics, Blotting, Western, Cell Line, Cell Survival, Cells, Cultured, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Humans, Microscopy, Confocal, Protein Transport, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Ribonucleoproteins genetics, Transfection, SS-B Antigen, Autoantigens metabolism, Cytoplasm metabolism, Granzymes metabolism, Ribonucleoproteins metabolism
- Abstract
Our recent report demonstrated that apoptosis-specific autoantibodies against granzyme B-induced cleavage fragments of SS-B (La) were found in the sera from patients with primary Sjögren's syndrome. The objective of this study was identified by the intracellular redistribution of La autoantigen during granzyme B-induced apoptosis. We developed green fluorescence protein (GFP)-La and GFP-LaDelta220 (generation of granzyme B-specific cleavage of La protein) fusion proteins. GFP-La protein was localized in the nucleus, whereas the GFP-LaDelta220 protein predominantly existed in the cytoplasm in transformed A293T cells. Nuclear GFP-La protein was translocated to cytoplasm after granzyme B enriched YT cells incubation. La protein in human salivary grand HSG cells is cleaved and translocated from the nucleus to the cytoplasm after YT cell co-cultivation. These results suggest that La protein is cleaved by granzyme B and N-terminal La fragment (27 kD) translocated to the cytoplasm, thus leading to a novel autoantibody production during granzyme B-mediated cytotoxicity.
- Published
- 2007
- Full Text
- View/download PDF
12. Activation of protein phosphatase causes alternative splicing of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): potential effect on immune surveillance.
- Author
-
Kamachi M, Aramaki T, Tanimura S, Ichinose K, Fujikawa K, Iwamoto N, Yoshizaki A, Ida H, Kawakami A, Kohno M, and Eguchi K
- Subjects
- Alternative Splicing immunology, Apoptosis immunology, Enzyme Activation, Humans, Immunity, Innate genetics, Immunity, Innate immunology, Jurkat Cells, Phosphoprotein Phosphatases immunology, Protein Phosphatase 1, TNF-Related Apoptosis-Inducing Ligand immunology, U937 Cells, Alternative Splicing genetics, Apoptosis genetics, Phosphoprotein Phosphatases genetics, TNF-Related Apoptosis-Inducing Ligand genetics
- Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) belongs to the TNF superfamily of proteins. It is highly expressed on natural killer cells, cytotoxic T lymphocytes, and monocytes after stimulation, and plays a critical role in immune surveillance. Two splice variants of TRAIL were identified recently that show no proapoptotic activity. Phosphorylation level in splicing factors, serine-arginine-rich (SR) and heterogeneous ribonucleoproteins (hnRNPs) govern the mRNA splicing of several apoptosis-related genes. We characterized the apoptotic stimuli-mediated alternative splicing pattern of TRAIL and investigated the possible underlying mechanism of alternative splicing. Etoposide and cycloheximide induced alternative splicing, whereas staurosporine (a broad kinase inhibitor) blocked both constitutive and alternative splicing. De novo ceramide synthesis and subsequent protein phosphatase-1 (PP-1) activation enhanced the alternative splicing, as did TNF-alpha but not interferon alpha (IFN-alpha) stimulation. We demonstrated that TRAIL alters gene expression through mRNA splicing and may change proapoptotic potential in response to cytokine stimulation.
- Published
- 2007
- Full Text
- View/download PDF
13. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation.
- Author
-
Zhang XJ, Katsuta Y, Akimoto T, Ohsuga M, Aramaki T, and Takano T
- Subjects
- Animals, Bile Ducts, Capillaries physiopathology, Enzyme Inhibitors pharmacology, Hepatopulmonary Syndrome metabolism, Hepatopulmonary Syndrome physiopathology, Hypoxia epidemiology, Hypoxia etiology, Hypoxia metabolism, Ligation, Male, Microspheres, NG-Nitroarginine Methyl Ester pharmacology, Oxygen blood, Prevalence, Pulmonary Artery, Rats, Rats, Sprague-Dawley, Hypoxia physiopathology, Nitric Oxide metabolism, Pulmonary Circulation, Vasodilation
- Abstract
Background/aims: Nitric oxide (NO) has been suggested as the major cause of pulmonary vascular dilatation and hypoxemia in hepatopulmonary syndrome (HPS). The aim of this study was to assess the effect of NO on arterial oxygenation in rats with common bile duct ligation (CBDL rats), a model of HPS., Methods: Arterial blood gases were measured in 44 CBDL rats and 44 Sham rats under unrestrained conditions. Intrapulmonary shunting was assessed with (141)Ce-labeled microspheres (15-mum diameter) and serum nitrate/nitrite levels were measured by HPLC. The effect of NOS inhibition on A-aDO(2) was studied using L-NAME., Results: A decrease of PaO(2) below 82.7 mmHg (the mean value-2sigma in Sham rats) was seen in 43% of CBDL rats. Intrapulmonary shunting was greater in CBDL rats than in Sham rats (P<0.001). A correlation between the extent of shunting and A-aDO(2) was found in all animals studied (r=0.89, P<0.001, n=16). Serum levels of nitrate/nitrite increased significantly across the lungs, and the increase was significantly correlated with A-aDO(2) in the total population of animals studied. Administration of L-NAME to CBDL rats achieved a significant improvement of A-aDO(2)., Conclusions: These results suggest that pulmonary vascular dilatation due to NO leads to hypoxemia in CBDL rats.
- Published
- 2003
- Full Text
- View/download PDF
14. Effectiveness of transcoronary chemoembolization for metastatic right ventricular tumor derived from hepatocellular carcinoma.
- Author
-
Kotani E, Kiuchi K, Takayama M, Takano T, Tabata M, Aramaki T, and Kawamata H
- Subjects
- Aged, Carcinoma, Hepatocellular complications, Carcinoma, Hepatocellular secondary, Coronary Angiography, Coronary Vessels, Echocardiography, Female, Heart Neoplasms complications, Heart Neoplasms secondary, Heart Ventricles, Humans, Liver Neoplasms complications, Liver Neoplasms pathology, Ventricular Outflow Obstruction diagnosis, Ventricular Outflow Obstruction etiology, Ventricular Outflow Obstruction therapy, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Carcinoma, Hepatocellular therapy, Chemoembolization, Therapeutic methods, Heart Neoplasms therapy, Liver Neoplasms therapy
- Abstract
A right ventricular outflow tract was partially obstructed by a metastatic tumor from a hepatocellular carcinoma. This tumor was treated via chemoembolization of the right coronary artery, which resulted in tumor regression and improvement of the patient's symptoms.
- Published
- 2000
- Full Text
- View/download PDF
15. Plasma volume contraction in portal hypertension.
- Author
-
Katsuta Y, Aramaki T, Sekiyama T, Satomura K, Okumura H, and Okumura K corrected to Okumura H]
- Subjects
- Aged, Aldosterone blood, Blood Pressure physiology, Dose-Response Relationship, Drug, Female, Furosemide therapeutic use, Hemodynamics physiology, Humans, Hypertension, Portal complications, Hypertension, Portal drug therapy, Liver blood supply, Liver physiology, Liver Cirrhosis complications, Liver Cirrhosis physiopathology, Male, Middle Aged, Regional Blood Flow drug effects, Regional Blood Flow physiology, Spironolactone therapeutic use, Time Factors, Hypertension, Portal physiopathology, Plasma Volume
- Abstract
The effect of blood volume contraction induced by a 4-week regimen of spironolactone (100 mg/day) or furosemide (40 mg/day) on the hepatic venous pressure gradient (HVPG), an indicator of portal hypertension, was evaluated in patients with cirrhosis and no ascites. In the spironolactone group (n = 15), HVPG decreased significantly from 16.5 +/- 0.9 mmHg (mean +/- S.E.M.) to 12.9 +/- 1.0 mmHg (P < 0.005) and total blood volume contracted significantly from 4338 +/- 231 ml to 4006 +/- 203 ml (n = 14, P < 0.01). Although the HVPG changes did not correlate significantly with changes in measured total blood volume or in simultaneously determined systemic haemodynamics, a significant inverse correlation (r = -0.74, P < 0.01, n = 12) was found between the HVPG change and posttreatment plasma aldosterone levels, attesting to the effectiveness of spironolactone therapy in lowering HVPG. In the furosemide group (n = 10), neither HVPG (13.7 +/- 0.3 mmHg vs. 13.6 +/- 0.9 mmHg) nor total blood volume (4961 +/- 153 ml vs. 4964 +/- 162 ml) declined significantly. These results show that long-term administration of spironolactone to patients with cirrhosis and no ascites produced a significant reduction in HVPG that may have been due to gradual, sustained volume contraction. Thus, spironolactone may prove to be an effective treatment for portal hypertension in cirrhosis without ascites.
- Published
- 1993
- Full Text
- View/download PDF
16. (D-Ala, D-Leu) enkephalin reduces the binding of GTP in hippocampal membranes.
- Author
-
Aramaki T, Saito K, Shinno E, Ohnishi T, Ooi Y, Maeda S, and Inoki R
- Subjects
- Affinity Labels, Animals, Autoradiography, Azides metabolism, Electrophoresis, Polyacrylamide Gel, Guanosine Triphosphate analogs & derivatives, Guanosine Triphosphate metabolism, Hippocampus metabolism, In Vitro Techniques, Indoles pharmacology, Male, Membranes drug effects, Membranes metabolism, Morphinans pharmacology, Rats, Rats, Sprague-Dawley, Enkephalin, Leucine-2-Alanine pharmacology, GTP-Binding Proteins metabolism, Guanosine 5'-O-(3-Thiotriphosphate) metabolism, Hippocampus drug effects, Naltrexone analogs & derivatives
- Abstract
The effect of (D-Ala, D-Leu) enkephalin (DADLE) on the binding of GTP in hippocampal preparations was studied. It was observed that treatment of hippocampal slices with 10(-5) -5 x 10(-5) M DADLE followed by the preparation of membrane fractions reduced the binding of 35S-GTP-gamma-S. There was no change in the affinity of the binding. This decrease of 35S-GTP-gamma-S binding was reversed when 5 x 10(-5) M naltrindole was included. The effect was not observed when the membrane fractions were incubated with DADLE. Photoaffinity labeling with the use of 32P P3-(4-azidoanilido)-P1 5'-GTP followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography revealed the incorporation of radioactivity into molecular mass of the 43 kDa and 33-34 kDa proteins. 32P Photolabeling of both the 43 kDa and 33-34 kDa bands decreased following treatment of hippocampal slices with 10(-4) M DADLE. These results suggested that DADLE reduces the GDP-GTP exchange in hippocampal membranes.
- Published
- 1993
- Full Text
- View/download PDF
17. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
- Author
-
Aramaki T, Sekiyama T, Katsuta Y, Kurokawa H, Komeichi H, Tsutsui H, Terada H, Ohsuga M, Satomura K, and Okumura H
- Subjects
- Adrenergic beta-Antagonists therapeutic use, Adult, Aged, Blood Pressure drug effects, Blood Pressure physiology, Female, Hemodynamics drug effects, Hemodynamics physiology, Humans, Hypertension, Portal etiology, Hypertension, Portal physiopathology, Liver drug effects, Liver physiology, Liver Cirrhosis physiopathology, Male, Middle Aged, Propanolamines therapeutic use, Propranolol pharmacology, Propranolol therapeutic use, Time Factors, Vasodilator Agents therapeutic use, Adrenergic beta-Antagonists pharmacology, Hypertension, Portal drug therapy, Liver Cirrhosis complications, Propanolamines pharmacology, Vasodilation drug effects, Vasodilator Agents pharmacology
- Abstract
To study the long-term effects of pharmacological combination therapy, a comparison was made of the haemodynamic changes in patients with cirrhosis and portal hypertension following a 4-week treatment of propranolol or nipradilol, a new nonselective beta-blocker with nitrovasodilating effect. Nipradilol (12 mg/dag, n = 12) significantly diminished wedged hepatic venous pressure (WHVP, 25 +/- 16%), the hepatic venous pressure gradient (HVPG, 20 +/- 12%), and estimated hepatic blood flow (EHBF, 18 +/- 16%). Propranolol (30 mg/day, n = 11) also caused a significant reduction in WHVP (22 +/- 21%) and HVPG (24 +/- 21%), but not in EHBF. The percentage of portal pressure reduction and the frequency of nonresponders did not differ between the nipradilol and propranolol groups. Both agents reduced heart rate by approx. 20%. Nipradilol, however, did not cause a significant reduction in cardiac index (CI) versus a 14% reduction by propranolol. Pulmonary capillary wedge pressure and central venous pressure, an index of preload, were decreased slightly in the nipradilol group. When nonresponders were excluded, there was a significant correlation of the percentage of reduction between WHVP and CI or systemic vascular resistance, in the nipradilol group. These results indicate that nipradilol may have potent hypotensive effects on portal hypertension, similar but not superior to propranolol. Nipradilol, at the dosage used in the present study, did not appear to exert a nitrovasodilating effect to enhance the portal pressure reduction induced by beta-blocking action.
- Published
- 1992
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.